Roche Diagnostics Recalling Anti-TSHR Immunoassay Over Diagnosis Risk
Roche Diagnostics Operations recalled 1,300 Anti-TSHR immunoassay cassettes on November 21, 2025. Variability in results may lead to incorrect diagnoses and treatment delays. The recall affects multiple states across the U.S.